Last reviewed · How we verify
NCT05553418
Investigational On-body Injector Clinical Study
NA trial testing In-clinic wear first in Healthy Volunteers in 70 participants. Completed in 8 February 2023.
8 February 2023
Quick facts
| Lead sponsor | Becton, Dickinson and Company |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | other |
| Enrollment | 70 |
| Start date | 5 September 2022 |
| Primary completion | 8 February 2023 |
| Estimated completion | 8 February 2023 |
| Sites | 1 location across France |
Drugs / interventions tested
- In-clinic wear first
- Home wear first
Conditions studied
- Healthy Volunteers — all drugs for Healthy Volunteers →
Sponsor
Becton, Dickinson and Company — full company profile →
Who can join
18 and older, any sex, with Healthy Volunteers. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the clinical feasibility, performance, safety and acceptability of the On-body Injector (OBI) when applied to the arm or abdomen of healthy volunteers to inject placebo under the skin.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05553418
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy Volunteers
Currently open trials in the same condition.
- NCT07504003 — Influence of Training Session Duration on Improvements in Physiological Resilience to Exercise · NA · recruiting
- NCT07446400 — A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuva · Phase 1 · recruiting
- NCT07495813 — A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease · Phase 1 · recruiting
- NCT07499050 — A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity · Phase 1 · recruiting
- NCT07342114 — A Dose-Escalation Study of RO7875913 in Healthy Participants · Phase 1 · recruiting
Other Becton, Dickinson and Company trials
Trials by the same sponsor.
- NCT06632509 — BD SiteRite(TM) 9 Ultrasound System - Clinical Study · completed
- NCT06632496 — BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking Technology Clinical Study · completed
- NCT06604026 — Investigational Study With the BD PosiFlush™ SafeScrub on NADs · NA · recruiting
- NCT06426121 — Clinical Validation of BACTEC™ Plus Aerobic/F Culture Vials Compared With Equivalent Product · completed
- NCT05953363 — Prospective Clinical Evaluation of BD NRFit™ Devices and Accessories. · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05553418 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Becton, Dickinson and Company
- Last refreshed: 3 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05553418.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing